Drug recall D-0580-2026
Product
DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile, Rx only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol, Gujarat, India, NDC 72603-200-01.
Reason for recall
Presence of Particulate matter: Particulate matter identified as glass.
Lots and codes
Lot HAG2581B, expires: 05/31/2027
Recall details
- Recalling firm
- SUN PHARMACEUTICAL INDUSTRIES INC, Princeton, NJ
- Quantity
- 675 vials
- Distribution
- U.S. Nationwide
- Type
- Voluntary: Firm initiated
- Recall initiated
- May 12, 2026
Related products
- Doxorubicin Hydrochloride – drug information
- NDC 72603-103 Doxorubicin Hydrochloride · Doxorubicin Hydrochloride 2 mg/mL · NorthStar RxLLC
- NDC 72603-200 Doxorubicin Hydrochloride · Doxorubicin Hydrochloride 2 mg/mL · NorthStar RxLLC